Shield Therapeutics plc (AIM:STX)

United Kingdom · Delayed Price · Currency is GBP · Price in GBX

3.400

+0.100 (3.03%)

Nov 12, 2026, 3:57 PM GMT

Shield Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	36	105	21	52	18	96
Market Cap Growth	-49.99%	395.31%	-59.70%	186.53%	-80.96%	28.62%
Enterprise Value	49	116	31	46	16	73
Last Close Price	0.03	0.10	0.03	0.07	0.07	0.43

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	113.42	113.42	113.42	113.42	113.42
PS Ratio	0.82	2.83	0.82	5.10	4.01	63.24
PB Ratio	-	-9.34	-20.07	4.44	3.37	2.36
P/TBV Ratio	-	-	-	4.82	4.15	4.11

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.11	3.15	1.19	4.50	3.48	48.36

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-1.46	-2.00	-20.02	1.35	1.04	0.00
Debt / FCF Ratio	18.88	-	-	-	-	-
Net Debt / Equity Ratio	-0.97	-1.23	-15.07	0.42	0.52	-0.29
Net Debt / EBITDA Ratio	-3.74	-1.88	-0.89	-0.20	-0.11	0.64
Net Debt / FCF Ratio	12.55	-5.44	-2.92	-0.17	-0.15	0.64
Asset Turnover	1.01	0.81	0.61	0.35	0.14	0.04
Inventory Turnover	3.54	3.59	3.89	3.65	1.63	0.65
Quick Ratio	0.55	0.67	0.90	1.83	0.62	3.73
Current Ratio	0.75	0.90	1.16	2.28	0.95	4.64
Return on Equity (ROE)	-	-	-396.36%	-308.60%	-179.19%	-55.46%
Return on Assets (ROA)	-4.37%	-10.24%	-26.90%	-51.93%	-49.37%	-32.97%
Return on Capital Employed (ROCE)	-51.40%	-66.70%	-92.00%	-89.40%	-229.50%	-49.90%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-21.67%	-12.54%	-102.83%	-49.88%	-225.97%	-20.48%
FCF Yield	2.73%	-2.42%	-25.74%	-55.98%	-102.82%	-19.40%
Buyback Yield / Dilution	-16.25%	-33.81%	-8.33%	-209.85%	-14.08%	-74.36%